103 related articles for article (PubMed ID: 8958191)
21. Prediction of exercise tolerance in the chronic phase of myocardial infarction by using ventilatory gas analysis.
Tanabe K; Iwasaki T; Osada N; Omiya K; Yamamoto M; Itoh H; Murayama M; Sugai J; Yamada S; Yamasaki H
Jpn Circ J; 1993 Mar; 57(3):189-96. PubMed ID: 8464139
[TBL] [Abstract][Full Text] [Related]
22. Effects of exercise training on the recovery of the autonomic nervous system and exercise capacity after acute myocardial infarction.
Oya M; Itoh H; Kato K; Tanabe K; Murayama M
Jpn Circ J; 1999 Nov; 63(11):843-8. PubMed ID: 10598888
[TBL] [Abstract][Full Text] [Related]
23. Alpha-adrenergic and angiotensin II pressor sensitivity in hypertensive patients treated with an angiotensin-converting enzyme inhibitor.
Rosendorff C; Patton J; Radford HM; Kalliatakis B
J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S105-9. PubMed ID: 1382157
[TBL] [Abstract][Full Text] [Related]
24. Acute effects of cilazapril on coronary hemodynamics in patients with renovascular hypertension.
Magrini F; Reggiani P; Fratianni G; Morganti A; Zanchetti A
J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S128-33. PubMed ID: 1381789
[TBL] [Abstract][Full Text] [Related]
25. The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertension.
Ajayi AA; Elliott HL; Reid JL
Br J Clin Pharmacol; 1986 Aug; 22(2):167-75. PubMed ID: 3019375
[TBL] [Abstract][Full Text] [Related]
26. ACE inhibition with cilazapril improves myocardial perfusion to the ischemic regions during exercise: a pilot study.
Gasic S; Dudczak R; Korn A; Kleinbloesem C
J Cardiovasc Pharmacol; 1990 Feb; 15(2):227-32. PubMed ID: 1689417
[TBL] [Abstract][Full Text] [Related]
27. Exercise-induced changes in plasma atrial natriuretic peptide and brain natriuretic peptide concentrations in healthy subjects with chronic sleep deprivation.
Tanabe K; Yamamoto A; Suzuki N; Akashi Y; Seki A; Samejima H; Oya M; Murabayashi T; Nakayama M; Yokoyama Y; Osada N; Omiya K; Itoh H; Miyake F; Murayama M
Jpn Circ J; 1999 Jun; 63(6):447-52. PubMed ID: 10406584
[TBL] [Abstract][Full Text] [Related]
28. Effect of angiotensin converting enzyme inhibition on renal response to atrial natriuretic factor in rats.
Wu JN; Huang WC
Proc Natl Sci Counc Repub China B; 1988 Jul; 12(3):186-93. PubMed ID: 2977443
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin-converting enzyme inhibitors in preventing remodeling and development of heart failure after acute myocardial infarction: results of the German multicenter study of the effects of captopril on cardiopulmonary exercise parameters (ECCE).
Kleber FX; Sabin GV; Winter UJ; Reindl I; Beil S; Wenzel M; Fischer M; Doering W
Am J Cardiol; 1997 Aug; 80(3A):162A-167A. PubMed ID: 9293972
[TBL] [Abstract][Full Text] [Related]
30. Effects of ACE inhibition with cilazapril on splanchnic and systemic haemodynamics in man.
Gasic S; Heinz G; Kleinbloesem C; Korn A
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):225S-234S. PubMed ID: 2548552
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of the effects of the angiotensin converting enzyme inhibitor cilazapril on diurnal blood pressure.
Nakanishi T; Takahashi H; Nishimura M; Yoshimura M
Clin Ther; 1993; 15(2):294-303. PubMed ID: 8519038
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin-converting enzyme (ACE)-inhibition in cirrhosis. Pharmacokinetics and dynamics of the ACE-inhibitor cilazapril (Ro 31-2848).
Gross V; Treher E; Haag K; Neis W; Wiegand U; Schölmerich J
J Hepatol; 1993 Jan; 17(1):40-7. PubMed ID: 8445218
[TBL] [Abstract][Full Text] [Related]
33. The 24 h blood pressure responses of hypertensives to a once-a-day cilazapril regimen.
Fernandez PG; Bolli P; Lee C
Can J Cardiol; 1990 Mar; 6(2):53-8. PubMed ID: 2138051
[TBL] [Abstract][Full Text] [Related]
34. Antihypertensive treatment with cilazapril. Resting and exercise blood pressure, hormones and enzymes.
Breithaupt K; Belz GG; Spielmanns DG; Neis W; Kirchner P
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):136-41. PubMed ID: 2159308
[TBL] [Abstract][Full Text] [Related]
35. Effects of single doses of the converting enzyme inhibitor cilazapril in normal volunteers.
Fasanella d'Amore T; Bussien JP; Nussberger J; Waeber B; Turini GA; Brunner HR; Kler L; Francis RJ
J Cardiovasc Pharmacol; 1987 Jan; 9(1):26-31. PubMed ID: 2434790
[TBL] [Abstract][Full Text] [Related]
36. Effect of cilazapril on regional left ventricular wall thickness and chamber dimension following acute myocardial infarction: in vivo assessment using MRI.
Saeed M; Wendland MF; Seelos K; Masui T; Derugin N; Higgins CB
Am Heart J; 1992 Jun; 123(6):1472-80. PubMed ID: 1534434
[TBL] [Abstract][Full Text] [Related]
37. Selective activation of atrial natriuretic peptide in patients with myocardial infarction and mild left ventricular dysfunction.
Bellone P; Derchi G; Tommasini G; Biorci ML; Randazzo M; Primarolo P; Vecchio C
Int J Cardiol; 1993 Dec; 42(2):115-20. PubMed ID: 8112915
[TBL] [Abstract][Full Text] [Related]
38. The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs.
Li Y; Li WM; Gong YT; Li BX; Liu W; Han W; Dong D; Sheng L; Xue JY; Zhang L; Chu S; Yang BF
Basic Res Cardiol; 2007 May; 102(3):245-56. PubMed ID: 17268887
[TBL] [Abstract][Full Text] [Related]
39. Influence of angiotensin converting enzyme inhibition on exercise performance and clinical symptoms in chronic heart failure: a multicentre, double-blind, placebo-controlled trial.
Dössegger L; Aldor E; Baird MG; Braun S; Cleland JG; Donaldson R; Jansen LJ; Joy MD; Marin-Neto JA; Nogueira E
Eur Heart J; 1993 Jul; 14 Suppl C():18-23. PubMed ID: 8365423
[TBL] [Abstract][Full Text] [Related]
40. Influence of aerobic exercise training on brain natriuretic peptide secretion in patients in the chronic phase of myocardial infarction.
Yamamoto A; Tanabe K; Yokoyama Y; Itoh H; Murayama M
Jpn Circ J; 1998 Sep; 62(9):658-64. PubMed ID: 9766703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
